trending Market Intelligence /marketintelligence/en/news-insights/trending/vqbwxauzidldh0srbwdmoa2 content esgSubNav
In This List

Compugen appoints chief medical officer

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Compugen appoints chief medical officer

Compugen Ltd. appointed Henry Adewoye to the newly created role of chief medical officer, effective March 26.

Adewoye most recently served as clinical director in oncology clinical research at Gilead Sciences Inc.

Tel Aviv-based Compugen is a therapeutic discovery and development company working to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy.